XTX Topco Ltd - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2022$41,000
-14.6%
23,724
-46.3%
0.01%
-63.0%
Q4 2021$48,000
-62.2%
44,172
-7.9%
0.03%
-37.2%
Q2 2021$127,000
+78.9%
47,951
+143.8%
0.04%
+26.5%
Q1 2021$71,00019,6720.03%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders